SVP, Greater China for EVERSANA Services and has significant experience in healthcare in China.
Prior to joining EVERSANA, Roberto was Managing Director of Cardinal Health China (KDL) within Shanghai Pharmaceutical Group (SPG), the 2nd largest healthcare distributor in China and one of the largest state-owned enterprises in China and revenues > $25B USD and Fortune 500 company.
Roberto joined SPG through its acquisition of KDL where he was Chief Commercial Officer.